Moheb Afzali F, Heshmati M, Salimi A, Kalanaky S, Fakharzadeh S, Hafizi M, et al. BCc1, a Chelation-Based Nanomedicine, modulates splenic cytokine networks toward a profile associated with antitumor immunity in 4T1 breast tumor–bearing mice. Arch Adv Biosci [Internet]. 2026 May 13 [cited 2026 Jul. 23];17(1):1-13. Available from: https://journals.sbmu.ac.ir/aab/article/view/52004